Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
tbh Skincare is an Australian consumer healthcare company that develops and markets scientifically-backed dermatological products, with a primary focus on acne management. The company's core innovation is a patented technology designed to disrupt the protective biofilm of acne-causing bacteria, which enhances the efficacy of traditional treatments. Its product portfolio includes topical creams, cleansers, and hydrocolloid patches tailored for sensitive and breakout-prone skin. Founded in 2020, the brand quickly gained traction in the direct-to-consumer space before expanding into major retail partnerships. In 2023, tbh Skincare was acquired by York Health Co to accelerate its global growth and product development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on tbh Skincare.